Cck Positive Interneurons

📖 Wiki Page

cell1044 wordssynced 2026-04-02

Cholecystokinin-Positive Interneurons (CCK+)

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Cck Positive Interneurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0002277](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002277)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0002277](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002277)</td>
</tr>
</table>

Introduction

Cck Positive Interneurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

CCK+ interneurons are a major class of cortical GABAergic neurons characterized by cholecystokinin expression. These neurons represent approximately 25-30% of cortical interneurons and play crucial roles in regulating pyramidal neuron excitability, network oscillations, and cognitive function [1]. [@freund1990]

Overview

flowchart TD CCK["CCK"] -->|"interacts with"| Nucleus_Tractus_Solitarius["Nucleus Tractus Solitarius"] CCK["CCK"] -->|"biomarker for"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] style CCK fill:#4fc3f7,stroke:#333,color:#000

...

Cholecystokinin-Positive Interneurons (CCK+)

Introduction

Overview

Mermaid diagram (expand to render)

Cholecystokinin-positive (CCK+) interneurons are among the most abundant interneuron populations in the cerebral cortex and hippocampus. Unlike parvalbumin (PV+) basket cells, CCK+ basket cells preferentially target the soma and proximal dendrites of pyramidal neurons, providing powerful perisomatic inhibition. CCK+ interneurons are distinguished by their expression of the neuropeptide cholecystokinin and the cannabinoid receptor type 1 (CB1), which mediates activity-dependent modulation of inhibition [2]. [@herkenham1990]

[@cobb1999]

Multi-Taxonomy Classification

Taxonomy Database Cross-References

PanglaoDB Marker Cross-References

Unknown (PanglaoDB):

External Database Links

[Cell Ontology (CL:0002277)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002277)
[OBO Foundry (CL:0002277)](http://purl.obolibrary.org/obo/CL_0002277)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

Unknown (PanglaoDB):

External Database Links

[Cell Ontology (CL:0002277)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002277)
[OBO Foundry (CL:0002277)](http://purl.obolibrary.org/obo/CL_0002277)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)

Structural Organization

Cellular Morphology

CCK+ interneurons exhibit diverse morphological subtypes:

CCK+ basket cells: Characterized by dense axonal arborizations forming perisomatic baskets around pyramidal neuron somata. The axon initial segment is a primary target.
Dendrite-targeting interneurons: Axons preferentially target distal dendrites of pyramidal neurons and interneurons
Axo-axonic cells: Some CCK+ neurons target axon initial segments (less common than PV+ axo-axonic cells)
Bipolar/bitufted cells: Elongated dendritic trees spanning cortical layers

Synaptic Connectivity

CCK+ interneurons receive diverse inputs:

Local pyramidal neurons: Excitatory feedback
Other interneurons: Cross-inhibition
Thalamocortical afferents: Sensory input integration
Subcortical modulators: Cholinergic, serotonergic inputs

Molecular Markers

Primary Markers

CCK: Cholecystokinin peptide (primary defining marker)
CNR1 (CB1): Cannabinoid receptor type 1 - highest expression in brain [3]
GAD1/GAD2: GABA synthesis enzymes
VGLUT3: Vesicular glutamate transporter (co-release glutamate)

Co-expressed Markers

CCK+ neurons often co-express:

PV (PVALB): Can be co-expressed in some subpopulations
CR (CALB2): Calretinin in subset
VIP: Vasoactive intestinal peptide (partial overlap)
nNOS: Neuronal nitric oxide synthase (subset)
Reelin (RELN): Some CCK+ basket cells

Transcription Factors

Lhx6: Required for CCK+ interneuron development
Npas1: CCK+ interneuron specification
Satb1: Chromatin regulator in CCK+ development

Electrophysiological Properties

Firing Patterns

CCK+ interneurons display characteristic firing properties:

Regular-spiking: Moderate firing rates
Adapting spike trains: Frequency adaptation during sustained depolarization
Low-threshold spiking: In some subtypes
Fast-spiking subset: Some CCK+ basket cells approach fast-spiking characteristics

Membrane Properties

Resting membrane potential: -65 to -70 mV
Input resistance: 150-300 MΩ
Membrane time constant: 10-20 ms
Action potential duration: 0.5-1.0 ms

Function

Perisomatic Inhibition

CCK+ basket cells provide powerful inhibition at the soma [4]:

Timing control: Precisely timed inhibition regulates pyramidal neuron spike timing
Gain modulation: Control input-output functions
Synchronization: Coordinate pyramidal neuron firing ensembles
Feedback inhibition: Respond to elevated excitatory activity

Network Oscillations

CCK+ interneurons contribute to cortical oscillations:

Gamma oscillations (30-80 Hz): CCK+ basket cells drive gamma through perisomatic inhibition
Theta oscillations (4-8 Hz): Phase coupling with hippocampal interneurons
Sharp wave-ripples: CCK+ cell activity during replay events

Modulation by Endocannabinoids

The CB1 receptor provides unique modulation [5]:

Depolarization-induced suppression of inhibition (DSI): Endocannabinoid release reduces CCK+ release
Activity-dependent plasticity: CB1 enables flexible circuit modulation
retrograde signaling: Postsynaptic activity triggers presynaptic modulation
Homeostatic regulation: Maintains excitation-inhibition balance

Vulnerability in Disease

Alzheimer's Disease

CCK+ interneuron alterations in AD [6]:

CCK level changes: Decreased CCK in cortex and hippocampus
Circuit dysfunction: Loss of perisomatic inhibition
Gamma oscillation deficits: Impaired gamma rhythms correlate with memory impairment
CB1 receptor changes: Altered endocannabinoid signaling
Early vulnerability: CCK+ neurons may show early deficits

Schizophrenia

CCK receptor alterations: Changed CCK receptor density in prefrontal cortex
Gamma band deficits: Impaired gamma oscillations linked to working memory deficits
Perisomatic inhibition: Altered inhibition affecting pyramidal neuron function
Genetic associations: CCK gene polymorphisms linked to schizophrenia risk

Epilepsy

CCK+ cell loss: Selective loss in temporal lobe epilepsy
Inhibition imbalance: Reduced perisomatic control
Hyperexcitability: Failure to suppress seizure-like activity
CB1 alterations: Changed cannabinoid modulation in epileptic tissue

Autism Spectrum Disorders

CCK signaling: Altered CCK and receptor expression
Circuit-specific deficits: Imbalanced excitation/inhibition
Social cognition: CCK's role in social behavior processing

Molecular Mechanisms

CCK Signaling

Cholecystokinin acts through CCK receptors [7]:

CCK1 receptors: Peripherally expressed, some CNS expression
CCK2 receptors: Primary CNS receptor
G-protein coupling: Activate phospholipase C pathway
Intracellular effects: Increase intracellular Ca²⁺, activate PKC

Endocannabinoid Signaling

CB1 receptor mechanisms:

Endocannabinoids: Anandamide (AEA), 2-arachidonoylglycerol (2-AG)
Presynaptic inhibition: Reduce GABA release probability
Activity-dependent: Locally released during high activity
Metabolic enzymes: FAAH, MAGL for degradation

Therapeutic Implications

Targeting CCK+ Circuits

Potential therapeutic approaches:

CCK agonists: Enhance CCK signaling for cognitive enhancement
CB1 modulators: Strategic modulation of endocannabinoid signaling
Gamma oscillation enhancers: Restore gamma rhythms
Circuit-specific interventions: Targeted manipulation of CCK+ networks

Clinical Significance

Biomarker potential: CCK levels as disease progression markers
Treatment targets: CCK receptor drugs in development
Cognitive enhancement: CCK's role in memory consolidation
Parvalbumin-Positive Interneurons
Somatostatin-Positive Interneurons
Vasoactive Intestinal Peptide (VIP+) Interneurons
Cortical Pyramidal Neurons
[GABAergic Neurons](/cell-types/gabaergic-neurons)](/entities/neurons)
[Alzheimer's Disease](/diseases/alzheimers-disease)
Gamma Oscillations

Background

The study of Cck Positive Interneurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[Nature Reviews Neuroscience: CCK interneurons](https://www.nature.com/articles/nrn.2017.51)interneurons)
[NCBI: CCK in neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/25890251/)neurodegeneration)
[Allen Brain Atlas: CCK expression](https://human.brain-map.org/)

📖 View canonical wiki page →